These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38396638)

  • 1. Exploring the Roles of Vitamins C and D and Etifoxine in Combination with Citalopram in Depression/Anxiety Model: A Focus on ICAM-1, SIRT1 and Nitric Oxide.
    Gammoh O; Ibrahim A; Yehya A; Alqudah A; Qnais E; Altaber S; Alrob OA; Aljabali AAA; Tambuwala MM
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamins C and D Exhibit Similar Antidepressant Effects to Escitalopram Mediated by NOx and FKBPL in a Stress-Induced Mice Model.
    Gammoh O; Ibrahim A; Qnais E; Alqudah A; Altaber S; Aljabali AAA; Tambuwala MM
    Nutrients; 2023 Jun; 15(12):. PubMed ID: 37375593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet and endothelial activity in comorbid major depression and coronary artery disease patients treated with citalopram: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy Trial (CREATE) biomarker sub-study.
    van Zyl LT; Lespérance F; Frasure-Smith N; Malinin AI; Atar D; Laliberté MA; Serebruany VL
    J Thromb Thrombolysis; 2009 Jan; 27(1):48-56. PubMed ID: 18188512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between citalopram and omega-3 fatty acids on anxiety and depression behaviors and maintaining the stability of brain pyramidal neurons in mice.
    Hosseini F; Khakpai F; Fazli-Tabaei S; Nasehi M; Zarrindast MR
    Neurosci Lett; 2024 Feb; 824():137688. PubMed ID: 38360146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positive allosteric modulation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptors differentially modulates the behavioural effects of citalopram in mouse models of antidepressant and anxiolytic action.
    Fitzpatrick CM; Larsen M; Madsen LH; Caballero-Puntiverio M; Pickering DS; Clausen RP; Andreasen JT
    Behav Pharmacol; 2016 Sep; 27(6):549-55. PubMed ID: 27341500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant Like Effect of Ascorbic Acid in Mice: Possible Involvement of NO-sGC-cGMP Signaling.
    Maratha S; Sharma V; Walia V
    Neurochem Res; 2022 Apr; 47(4):967-978. PubMed ID: 34825298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT1 Mediates Depression-Like Behaviors in the Nucleus Accumbens.
    Kim HD; Hesterman J; Call T; Magazu S; Keeley E; Armenta K; Kronman H; Neve RL; Nestler EJ; Ferguson D
    J Neurosci; 2016 Aug; 36(32):8441-52. PubMed ID: 27511015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated ketamine administration redeems the time lag for citalopram's antidepressant-like effects.
    Zhang GF; Liu WX; Qiu LL; Guo J; Wang XM; Sun HL; Yang JJ; Zhou ZQ
    Eur Psychiatry; 2015 Jun; 30(4):504-10. PubMed ID: 25795441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the role of NMDA receptor function in antidepressant-like activity. A new study with citalopram and fluoxetine in the forced swim test in mice.
    Wolak M; Siwek A; Szewczyk B; Poleszak E; Bystrowska B; Moniczewski A; Rutkowska A; Młyniec K; Nowak G
    Pharmacol Rep; 2015 Jun; 67(3):490-3. PubMed ID: 25933959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemical responses to antidepressants in the prefrontal cortex of mice and their efficacy in preclinical models of anxiety-like and depression-like behavior: a comparative and correlational study.
    Kobayashi T; Hayashi E; Shimamura M; Kinoshita M; Murphy NP
    Psychopharmacology (Berl); 2008 May; 197(4):567-80. PubMed ID: 18274731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergy of oxytocin and citalopram in modulating Itgb3/Chl1 interplay: Relevance to sensitivity to SSRI therapy.
    Stanić D; Oved K; Israel-Elgali I; Jukić M; Batinić B; Puškaš N; Shomron N; Gurwitz D; Pešić V
    Psychoneuroendocrinology; 2021 Jul; 129():105234. PubMed ID: 33930757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of nicotine on antidepressant and anxiolytic responses induced by citalopram and citicoline in mice.
    Khakpai F; Zarrindast MR
    Acta Neurobiol Exp (Wars); 2023; 83(2):194-202. PubMed ID: 37493535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential role of AMPA receptors in mouse tests of antidepressant and anxiolytic action.
    Andreasen JT; Fitzpatrick CM; Larsen M; Skovgaard L; Nielsen SD; Clausen RP; Troelsen K; Pickering DS
    Brain Res; 2015 Mar; 1601():117-26. PubMed ID: 25578259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of NMDA receptors and L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effects of escitalopram in the forced swimming test.
    Zomkowski AD; Engel D; Gabilan NH; Rodrigues AL
    Eur Neuropsychopharmacol; 2010 Nov; 20(11):793-801. PubMed ID: 20810255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isobolographic analysis of the antidepressant interaction in two-drug combinations of citalopram, bupropion, and scopolamine in mice.
    Mohammadi-Mahdiabadi-Hasani MH; Ebrahimi-Ghiri M; Khakpai F; Zarrindast MR
    Naunyn Schmiedebergs Arch Pharmacol; 2022 Jul; 395(7):827-837. PubMed ID: 35438334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of nitric oxide-cGMP pathway in the antidepressant-like effect of ascorbic acid in the tail suspension test.
    Moretti M; Freitas AE; Budni J; Fernandes SC; Balen Gde O; Rodrigues AL
    Behav Brain Res; 2011 Nov; 225(1):328-33. PubMed ID: 21802450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Brain-Derived Neurotrophic Factor and Hippocampal Dendritic Spine Density Are Associated with the Rapid Antidepressant-like Effect of Iron-citalopram and Iron-Imipramine Combinations in Mice.
    Kukuia KKE; Burns FB; Adutwum-Ofosu KK; Appiah F; Amponsah SK; Begyinah R; Koomson AE; Ferka YT; Tagoe TA; Amoateng P
    Neuroscience; 2023 May; 519():90-106. PubMed ID: 36948482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antidepressant- and anxiolytic-like effects following co-treatment with escitalopram and risperidone in rats.
    Kaminska K; Rogoz Z
    J Physiol Pharmacol; 2016 Jun; 67(3):471-80. PubMed ID: 27512008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citalopram--a review of pharmacological and clinical effects.
    Bezchlibnyk-Butler K; Aleksic I; Kennedy SH
    J Psychiatry Neurosci; 2000 May; 25(3):241-54. PubMed ID: 10863884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of salivary ICAM-1 and SIRT1 by disease modifying drugs in undepressed relapsing-remitting multiple sclerosis patients.
    Gammoh O; AlQudah A; Rob OAA; Hmedat A; Kifaieh A; Weshah F; Ennab W; Qnais E
    Mult Scler Relat Disord; 2022 Dec; 68():104257. PubMed ID: 36308972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.